Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis
Clinical trial NCT01894373 · COMPLETED
Trial details
- NCT number
- NCT01894373
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.